Intervention not reported
Intervention: high‐dose radiotherapy Comparison: low‐dose radiotherapy Outcome: neurocognitive impairment at 5 years after treatment · people with glioma surviving at least two years
It is very uncertain whether the intervention changes intervention: high‐dose radiotherapy Comparison: low‐dose… (very low certainty).
1 finding from 1 review
Intervention not reported
Intervention: chemoradiotherapy Comparison: radiotherapy Outcome: neurocognitive impairment at 3 years after treatment · people with glioma surviving at least two years
The intervention showed no clear difference in intervention: chemoradiotherapy Comparison: radiotherapy Outcome:… (low certainty).
1 finding from 1 review
Intervention not reported
Intervention: stereotactic conformal radiotherapy Comparison: radiotherapy Outcome: neurocognitive impairment at 5 years after treatment · people with glioma surviving at least two years
The intervention showed no clear difference in intervention: stereotactic conformal radiotherapy Comparison:… (low certainty).
1 finding from 1 review
Intervention not reported
Incidence of GTN (including low‐quality studies) · women with a molar pregnancy
The intervention may leads to lower incidence of GTN (including low‐quality studies) (low certainty).
1 finding from 1 review
Intervention not reported
Incidence of GTN (excluding low‐quality studies) · women with a molar pregnancy
The intervention may leads to lower incidence of GTN (excluding low‐quality studies) (low certainty).
1 finding from 1 review
Intervention not reported
Time to GTN diagnosis (days) · women with a molar pregnancy
The intervention may leads to higher time to GTN diagnosis (days) (low certainty).
1 finding from 1 review
Intervention not reported
Overall survival · people with non‐rhabdomyosarcoma soft tissue sarcoma
The intervention showed no clear difference in overall survival (high certainty).
1 finding from 1 review
Intervention not reported
Treatment‐related mortality · people with non‐rhabdomyosarcoma soft tissue sarcoma
1 finding from 1 review
Intervention not reported
Disease‐free survival · people with non‐rhabdomyosarcoma soft tissue sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Progression‐free survival · people with non‐rhabdomyosarcoma soft tissue sarcoma
The intervention showed no clear difference in progression‐free survival (high certainty).
1 finding from 1 review
Intervention not reported
Non‐hematologic toxicity grade 3 to 4 · people with non‐rhabdomyosarcoma soft tissue sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · people with non‐rhabdomyosarcoma soft tissue sarcoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall survival · Women with newly diagnosed epithelial ovarian cancer
The intervention leads to lower overall survival (high certainty).
1 finding from 1 review
Intervention not reported
hearing loss · Women with newly diagnosed epithelial ovarian cancer
The intervention leads to lower hearing loss (high certainty).
1 finding from 1 review
Intervention not reported
Progression‐free survival · Women with newly diagnosed epithelial ovarian cancer
The intervention leads to lower progression‐free survival (high certainty).
1 finding from 1 review
Intervention not reported
Severe adverse effects (G3/4) outcomes · Women with newly diagnosed epithelial ovarian cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
fever · Women with newly diagnosed epithelial ovarian cancer
The intervention leads to higher fever (high certainty).
1 finding from 1 review
Intervention not reported
fatigue · Women with newly diagnosed epithelial ovarian cancer
The intervention leads to higher fatigue (high certainty).
1 finding from 1 review
Intervention not reported
gastrointestinal AEs · Women with newly diagnosed epithelial ovarian cancer
The intervention leads to higher gastrointestinal AEs (high certainty).
1 finding from 1 review
Intervention not reported
infection · Women with newly diagnosed epithelial ovarian cancer
The intervention leads to higher infection (high certainty).
1 finding from 1 review